Biocept and Alliance Global FZ form agreement to market and distribute liquid biopsy testing in Middle East, Southeast Asia, and Africa

Published on: 13 Jul, 2018

Biocept Inc. (NASDAQ: BIOC) announced today that it has entered a provider agreement with Alliance Global FZ, LLC to market and distribute Biocept’s Target Selector liquid biopsy tests in the United Arab Emirates, and select countries in the Middle East, North & Sub-Saharan Africa, and Southeast Asia region.

"We are pleased to partner with Alliance Global to offer patients diagnosed with cancer access to our patented liquid biopsy testing," said Michael Nall, President and CEO of Biocept.

All diagnostic testing services under the agreement will be done at Biocept’s San Diego based CLIA-certified laboratory with Alliance Global taking responsibility for sales, marketing, distribution and reimbursement of the Company’s liquid biopsy platform.

"A major focus will be to use Biocept's testing services to support global biopharmaceutical companies in qualifying patients for their targeted therapies. We feel that Biocept's Target Selector™ assays with industry-leading sensitivity are uniquely suited for this application,"

The Company has not disclosed any additional terms of the agreement.

Following the agreement announcement, Biocept shares soared over 70%.

Ratings

Ratings
  • 1075Views
  • 2Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Nelson Cheng

Email: nelson@financialinsiders.com

@Newsletter

Sign Up for Weekly Updates

Related Posts

12 Jul, 2017 634
21 Aug, 2017 493
19 Sep, 2017 509
27 Sep, 2017 2696

2 Comments

Loans

Oct 12, 2018 at 06 11 am

credit loans guaranteed approval loan 500 credit loans guaranteed approval credit loans

REPLY (0)

Best Payday Loan

Oct 16, 2018 at 12 49 pm

credit loans guaranteed approval credit loans guaranteed approval no credit loans poor credit loans guaranteed approval

REPLY (0)